DDC Antikörper (N-Term)
Kurzübersicht für DDC Antikörper (N-Term) (ABIN5688877)
Target
Alle DDC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Affinity Purified
-
Immunogen
- Peptide from N-terminus region of human DOPA decarboxylase (DDC), conjugated to keyhole limpet hemocyanin (KLH).
-
-
-
-
Applikationshinweise
- The antibody has been directly tested for reactivity in Western blots in bovine, canine, guinea pig, human, rabbit, rat and sheep tissues.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 100 μLin 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per mL BSA and 50 % glycerol.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- DOPA Decarboxylase antibody can be stored at -20°C and is stable at -20°C for at least 1 year.
-
-
- DDC (Dopa Decarboxylase (Aromatic L-Amino Acid Decarboxylase) (DDC))
-
Andere Bezeichnung
- DOPA Decarboxylase
-
Hintergrund
- DOPA decarboxylase (aromatic L-amino acid decarboxylase, AADC, DDC) catalyzes the second reaction in the biosynthesis of catecholamines and serotonin (Waymire and Haycock, 2002, Berry et al., 1996, Haycock et al., 2003). It is also involved in the biosynthesis of trace amines. DDC antibodies can therefore be used as markers for dopaminergic, noradrenergic and serotonergic neurons in a variety of applications including depression, schizophrenia, Parkinson's disease and drug abuse (Kish et al., 2001, Zhu et al., 2000, Zhu et al., 1999).
-
Molekulargewicht
- 55 kDa
-
Gen-ID
- 1644
-
UniProt
- P20711
-
Pathways
- Dopaminergic Neurogenesis
Target
-